Cyclooxygenase (COX)-2 is one of the rate-limiting enzymes in the conversion of arachidonic acid to prostaglandins and other eicosanoids. Recent studies have shown enhanced expression of COX-2 in cancer cells of several tissues. We investigated the expression of COX-2 and prostaglandin (PG) E 2 prod
Expression of cyclooxygenase-2 (COX-2) in human esophageal cancer and in vitro inhibition by a specific COX-2 inhibitor, NS-398
β Scribed by HONG-PING YU; LU-YUAN SHI; WEN-HONG LU; YAN-HUA SU; YUAN-YUAN LI; SHUN-QING XU
- Book ID
- 108949841
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 90 KB
- Volume
- 19
- Category
- Article
- ISSN
- 0815-9319
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Elevated prostaglandin E(2) (PGE(2)) production is a common feature of human malignancies. This activity has often been attributed to increased metabolic activity of the cyclooxygenase enzymes, although a direct comparison of these 2 parameters i.e., prostaglandin production and cox protein expressi
## Abstract Apigenin is a nonmutagenic bioflavonoid that has been shown to be an inhibitor of mouse skin carcinogenesis induced by the twoβstage regimen of initiation and promotion with dimethylbenzanthracene (DMBA) and 12βOβtetradecanoylphorbolβ13βacetate (TPA). These DMBA/TPAβinduced squamous cel